We continually innovate and are committed to providing our clients with certified, best-in-class technology. We also offer a team of Meaningful Use Advisors, including Certified Meaningful Use Professionals, as well as a number of digital resources, to help answer your Meaningful Use questions.

Flatiron Health OncoEMR® version 2.8 is ONC Health IT 2015 Edition compliant (Product Number: 15.04.04.3010.Onco.28.01.1.181214; certified on December 14, 2018).

 

OncoEMR has certified the below functionality against the ONC 2015 requirements.

Criteria:

170.315 (a)(1): Computerized Provider Order Entry (CPOE) – Medications, 170.315 (a)(2): CPOE – Laboratory, 70.315 (a)(3): CPOE – Diagnostic Imaging, 170.315 (a)(4): Drug-Drug, Drug-Allergy Interaction Checks for CPOE, 170.315 (a)(5): Demographics, 170.315 (a)(6): Problem List, 170.315 (a)(7): Medication List, 170.315 (a)(8): Medication Allergy List, 170.315 (a)(9): Clinical Decision Support, 170.315 (a)(10): Drug-Formulary and Preferred Drug List Checks, 170.315 (a)(11): Smoking Status, 170.315 (a)(12): Family Health History, 170.315 (a)(13): Patient-Specific Education Resources, 170.315 (a)(14): Implantable Device List, 170.315 (b)(1): Transitions of Care, 170.315 (b)(2): Clinical Information Reconciliation and Incorporation, 170.315 (b)(3): Electronic Prescribing, 170.315 (b)(4): Common Clinical Data Set Summary Record – Create, 170.315 (b)(5): Common Clinical Data Set Summary Record – Receive, 170.315 (b)(6): Data Export, 170.315 (c)(1): Clinical Quality Measures – Record and Export, 170.315 (d)(1): Authentication, Access Control, Authorization, 170.315 (d)(2): Auditable Events and Tamper-Resistance, 170.315 (d)(3): Audit Report(s), 170.315 (d)(4): Amendments, 170.315 (d)(5): Automatic Access Time-out, 170.315 (d)(6): Emergency Access, 170.315 (d)(7): End-User Device Encryption, 170.315 (d)(8): Integrity, 170.315 (d)(9): Trusted Connection, 170.315 (d)(11): Accounting of Disclosures, 170.315 (e)(1): View, Download, and Transmit to 3rd Party, 170.315 (e)(2): Secure Messaging, 170.315 (e)(3): Patient Health Information Capture, 170.315 (f)(1): Transmission to Immunization Registries, 170.315 (g)(2): Automated Measure Calculation, 170.315 (g)(3): Safety-Enhanced Design, 170.315 (g)(4): Quality Management System, 170.315 (g)(5): Accessibility-Centered Design, 170.315 (g)(6): Consolidated CDA Creation, 170.315 (g)(7): Application Access – Patient Selection, 170.315 (g)(8): Application Access – Data Category Request, 170.315 (g)(9): Application Access – All Data Request

OncoEMR has certified the below CQM’s for use of ONC 2015 certified technology.

CQMs:

CMS68: Documentation of Current Medications in the Medical Record

See certification here.

OncoEMR is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

OncoEMR requires a one-time implementation fee for installation plus annual subscription fees which cover software licenses, customer support, software upgrades and services required to meet Meaningful Use objectives and measures. We have also partnered with MaxMD to help users deliver electronic referrals and DrFirst for controlled substance e-prescribing functionality in OncoEMR. Please note that there are additional one-time and/or annual vendor fees associated with the use of these services. There are no known limitations that a user may encounter in the course of implementing and using these Health IT Module’s capabilities, whether to meet meaningful use objectives and measures or to achieve any other use within the scope of the Health IT’s Certification.

Mandatory Disclosure: The data that’s exposed to the practice for exchange or portability is limited by use and scope.  We do not make every piece of data available to the practice.